Trials / Conditions / Pseudomembranous Colitis

Pseudomembranous Colitis

10 registered clinical trials studyying Pseudomembranous Colitis.

Status	Trial	Sponsor	Phase
Completed	Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection NCT03427229	Catholic University of the Sacred Heart	Phase 2
Withdrawn	Addition of Lactobacillus to Metronidazole in Treatment of CDAD NCT00304863	Michael E. DeBakey VA Medical Center	Phase 4
Completed	A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea NCT00382304	Genzyme, a Sanofi Company	Phase 2
Completed	Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis NCT00304889	Michael E. DeBakey VA Medical Center	—
Completed	Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea NCT00304876	Michael E. DeBakey VA Medical Center	—
Completed	Response of Clostridium Difficile Infection to Metronidazole Therapy NCT00304369	Michael E. DeBakey VA Medical Center	—
Completed	A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Assoc NCT00106509	Genzyme, a Sanofi Company	Phase 3
Completed	Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody NCT00304408	Michael E. DeBakey VA Medical Center	—
Completed	Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment NCT00182429	McMaster University	Phase 3
Completed	Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection NCT00304356	Daniel M. Musher MD	Phase 3